Abstract 1649: Discovery of first-in-class potent and selective oral degraders of KAT6A that demonstrate anti-cancer activity in pre-clinical models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Monisha Sivakumar, Sarah Pawley, Anthony Reichelderfer, Corey Basch, Jimin Park, Jessica Burtell, Chaoyi Xu, Min Wang, Chun Chen, Justin Kurian, Joy Cote, Miles Cowart, Stephanie Rodgers, Amy Crossan, Joseph Rager, Koichi Ito, Sandy Geeganage, SangHyun Lee, Andrew Combs, Peggy Scherle, Andrew Buesking, Jack Carter
Institution: Prelude Therapeutics Incorporated (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409628051